<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04654728</url>
  </required_header>
  <id_info>
    <org_study_id>Medipol Transplant</org_study_id>
    <nct_id>NCT04654728</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Study Comparing ePTFE Versus Dacron Graft for Anterior Sector Venous Drainage in Right Lobe Living Donor Liver Transplantation</brief_title>
  <official_title>Prospective Randomized Study Comparing ePTFE Versus Dacron Graft Donor Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medipol University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medipol University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Living donor liver transplantation (LDLT) using the right lobe (RL) has created a significant&#xD;
      increase in graft supply worldwide. However, it is a technically demanding procedure&#xD;
      particularly because of the unique functional anatomic characteristics of hepatic venous&#xD;
      drainage [1].&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the absence of an adequate drainage of the anterior sector (AS) veins, the consequent&#xD;
      venous congestion in the RL graft may result in impaired graft regeneration, immediate liver&#xD;
      dysfunction, and graft loss even in a liver graft of adequate size [2]. To overcome this&#xD;
      problem, Lee et al. [3] introduced the concept of modified RL graft in which the branches of&#xD;
      the middle hepatic vein (MHV) was drained using interposition vascular grafts. Although, the&#xD;
      issue of when and how the MHV branches should be drained has been controversial since then,&#xD;
      reconstruction of segment 5 and 8 veins using an interposition graft has become a standard&#xD;
      procedure during RL LDLT. The vascular graft of choice in this procedure has been&#xD;
      cryopreserved homologous vein graft, which provides excellent patency with low infection&#xD;
      risk. However, such grafts are often unavailable, particularly in programs where deceased&#xD;
      donors are scarce and surgeons must rely on synthetic grafts such as expanded&#xD;
      polytetrafluoroethylene (ePTFE) and polyethylene terephthalate (DacronÂ®). Since we have&#xD;
      developed an &quot;intent-to-drain&quot; policy in our LDLT program, we have been using Dacron grafts&#xD;
      exclusively [4]. Although, complications such as early graft thrombosis, graft infection, and&#xD;
      hollow viscous migration remain as major concerns, the safety and efficacy of both ePTFE and&#xD;
      Dacron grafts in LDLT has been proven [5, 6]. However, to date, none of the previous studies&#xD;
      have specifically compared these two different prosthetic materials, addressing graft patency&#xD;
      and complication rates in patients undergoing LDLT. The aim of our study is to compare AS&#xD;
      venous outflow reconstruction using ePTFE vs. Dacron grafts for their patency and infection&#xD;
      rates and outcomes with respect to graft and patient survival in RL LDLT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 24, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be equally randomized into two groups using sealed envelope system. For anterior sector venous drainage, ePTFE vascular grafts (straight or bifurcated) in group 1, and Dacron grafts(straight or bifurcated) in 2 will be used as conduit.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>None(Open Label)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Graft patency at 6-month posttransplant</measure>
    <time_frame>6 months</time_frame>
    <description>Graft Patency</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft-related complications</measure>
    <time_frame>One Year</time_frame>
    <description>Rate of graft infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft survival</measure>
    <time_frame>One year</time_frame>
    <description>Morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient survival</measure>
    <time_frame>One Year</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft regeneration rate</measure>
    <time_frame>6 months</time_frame>
    <description>Graft regeneration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Patency and Infection Rates Due to Usage of PTFE vs.Dacron Grafts</condition>
  <arm_group>
    <arm_group_label>ePTFE graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, anterior sector of the right lobe graft will be reconstructed using ePTFE vascular grafts</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dacron graft</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In this group, anterior sector of the right lobe graft will be reconstructed using Dacron vascular grafts</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Active Comparator: ePTFE graft</intervention_name>
    <description>In this group, anterior sector of the right lobe graft will be reconstructed using Dacron vascular grafts</description>
    <arm_group_label>Dacron graft</arm_group_label>
    <arm_group_label>ePTFE graft</arm_group_label>
    <other_name>Other: Dacron graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Primary Adult Living Donor Liver Transplantation&#xD;
&#xD;
          2. Right Lobe graft with anterior sector venous outflow reconstruction -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Right Lobe graft without anterior sector venous outflow reconstruction&#xD;
&#xD;
          2. Liver re-transplantation -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat Dayangac, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Study Chief</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ATIF TEKIN, M.D.</last_name>
    <phone>+905321007771</phone>
    <email>dr.atiftekin@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahmut Zenciroglu, M.D.</last_name>
    <phone>+905064919779</phone>
    <email>mahmutzenciroglu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medipol University Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34214</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ATIF TEKIN, M.D.</last_name>
      <phone>+905321007771</phone>
      <email>dr.atiftekin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>December 26, 2020</last_update_submitted>
  <last_update_submitted_qc>December 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medipol University Hospital</investigator_affiliation>
    <investigator_full_name>ATIF TEKIN</investigator_full_name>
    <investigator_title>General Surgery Residence</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

